Mail-in HPV Screening Program in NJ

Part of paid clinical trials in Newark, New Jersey.

Sponsor
Rutgers, The State University of New Jersey
Study ID
NCT07575217
Status
Enrolling By Invitation

Conditions

  • Cervical Cancer Screening

Eligibility Criteria

Sex
FEMALE
Age
30 Years - 75 Years
Healthy Volunteers
Accepted

Interventions

  • BD Onclarity HPV test — DIAGNOSTIC_TEST
    Self-collected cervicovaginal sample
  • Standard Pap Smear — DIAGNOSTIC_TEST
    Healthcare provider collected (in a hospital or clinical setting) cervicovaginal sample

Study Details

The purpose of this study is to help people who have missed their regular cervical cancer screening. The investigators are evaluating whether mailing an HPV self-sampling kit to participant home makes it easier and more convenient for people to get screened for cervical cancer. This study will also help to understand if people find this process acceptable and whether it is an effective way to improve screening rates.

Key Dates

First listed
May 8, 2026
Start date
Jul 20, 2026
Status verified
Jul 2026
Primary completion
Feb 28, 2027
Completion
Apr 16, 2027

Study Design

Enrollment
200 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING

Arms

  • Active Comparator: Standard Pap Smear
    Participants will have the option to choose a standard pap smear for cervical cancer screening
  • Experimental: HPV Self-Sampling Test
    Participants are able to opt-in for an at-home self-sampling HPV test for cervical cancer screening

Primary Outcome Measure

Completion of CC screening within 6 months of initial outreach. [ Time Frame: Outcome will be measured at 6 months post-initial outreach call. ]

Locations (1)

FacilityCityStateZIPSite coordinators
Rutgers New Jersey Medical SchoolNewarkNew Jersey07103-

Find similar trials in Newark, NJ

By research site
Rutgers New Jersey Medical School· Newark, NJ

Related Studies